Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 2Primary Ovarian Insufficiency 1Disease Progression 1Cisplatin Nephrotoxicity 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1

Interventions

Tamoxifen 2Paclitaxel 2pyrotinib 1pembrolizumab 1palbociclib 1iniparib 1darolutamide 1Thioctic Acid 1Pentoxifylline 1Metformin 1Letrozole 1Doxorubicin 1Cyclophosphamide 1Capecitabine 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Breast Cancer Female × Thioctic Acid × Clear all
NCT06703593 2025-10-01

Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

British University In Egypt

Phase 2 Completed
80 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡